Cas:273401-28-8 2-Acetamido-5-fluoro-4-nitrobenzoic acid manufacturer & supplier

We serve Chemical Name:2-Acetamido-5-fluoro-4-nitrobenzoic acid CAS:273401-28-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Acetamido-5-fluoro-4-nitrobenzoic acid

Chemical Name:2-Acetamido-5-fluoro-4-nitrobenzoic acid
CAS.NO:273401-28-8
Synonyms:N-Acetyl-5-fluoro-4-nitroanthranilic acid;2-acetylamino-5-fluoro-4-nitro-benzoic acid
Molecular Formula:C9H7FN2O5
Molecular Weight:242.16100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:115.71000
Exact Mass:242.03400
LogP:2.56320

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-Acetyl-5-fluoro-4-nitroanthranilic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-acetylamino-5-fluoro-4-nitro-benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-acetylamino-5-fluoro-4-nitro-benzoic acid Use and application,N-Acetyl-5-fluoro-4-nitroanthranilic acid technical grade,usp/ep/jp grade.


Related News: The business, home to popular brands such as arthritis gel Voltaren and vitamins line Centrum, generated over £10 billion in sales during 2020. (amino)difluoroborane manufacturers Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.” triimidotetraphosphoric acid suppliers The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. 3,5-Dibrom-1,2,4,3,5-trithiadiborolan(iB2) vendor & factory Expedite biocatalysis development by partnering with an API CDMO,Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.”